In Vitro Antibiotic Susceptibility of Initial Pseudomonas aeruginosa Isolates From United States Cystic Fibrosis Patients

被引：5

作者：

VanDevanter, Donald R. ^{[1
]}

Van Dalfsen, Jill M. ^{[2
]}

Burns, Jane L. ^{[3
,4
]}

Mayer-Hamblett, Nicole ^{[4
,5
]}

机构：

[1] Case Western Reserve Univ, Sch Med, Pediat, Cleveland, OH 44106 USA

[2] Univ Washington, Seattle Childrens Res Inst, Seattle, WA 98195 USA

[3] Univ Washington, Seattle Childrens Hosp, Infect Dis, Seattle, WA 98195 USA

[4] Univ Washington, Pediat, Seattle, WA 98195 USA

[5] Seattle Childrens Res Inst, Biomed Stat, Seattle, WA 98101 USA

来源：

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY | 2015年 / 4卷 / 02期

关键词：

cystic fibrosis; initial P aeruginosa; susceptibility;

D O I：

10.1093/jpids/pit052

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Chronic antibiotic suppression of cystic fibrosis (CF) infections has increased in the United States, as has isolation of Pseudomonas aeruginosa with reduced antibiotic susceptibility. However, analysis of the susceptibilities of 193 initial P aeruginosa clinical isolates suggests that antibiotic susceptibilities are comparable with wild-type strains despite expanded antipseudomonal treatment in the CF community.

引用

页码：151 / 154

页数：4

共 50 条

[1] Susceptibility of Pseudomonas aeruginosa isolates from cystic fibrosis patients to ciprofloxacin
Bauernfeind, A
Jungwirth, R
Ratjen, F
DRUGS, 1999, 58 (Suppl 2) : 209 - 210
[2] Susceptibility of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients to Ciprofloxacin
A. Bauernfeind
R. Jungwirth
F. Ratjen
Drugs, 1999, 58 : 209 - 210
[3] In Vitro Evaluation of Antibiotic Persistence in Pseudomonas aeruginosa and Staphylococcus aureus Isolates from Cystic Fibrosis Patients.
Fose, J.
Bruckbauer, D.
Jorgenson, M.
Rose, W.
AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 883 - 883
[4] Heterogeneous Antimicrobial Susceptibility Characteristics in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
Qin, Xuan
Zhou, Chuan
Zerr, Danielle M.
Adler, Amanda
Addetia, Amin
Yuan, Shuhua
Greninger, Alexander L.
MSPHERE, 2018, 3 (02)
[5] In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients
Manduru, M
Mihm, LB
White, RL
Friedrich, LV
Flume, PA
Bosso, JA
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) : 2053 - 2056
[6] INCIDENCE OF INITIAL PSEUDOMONAS AERUGINOSA IN CYSTIC FIBROSIS PATIENTS IN THE UNITED STATES: A SEASONAL AND CLIMATIC PERSPECTIVE
Psoter, K. J.
De Roos, A.
Wakefield, J.
Mayer, J.
Rosenfeld, M.
PEDIATRIC PULMONOLOGY, 2012, 47 : 384 - 384
[7] Antibiotic tolerance induced by lactoferrin in clinical Pseudomonas aeruginosa isolates from cystic fibrosis patients
Andrés, MT
Viejo-Diaz, M
Pérez, F
Fierro, JF
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (04) : 1613 - 1616
[8] PSEUDOMONAS-AERUGINOSA FROM CYSTIC-FIBROSIS PATIENTS - SUSCEPTIBILITY TESTING OF ORAL ISOLATES
KAUFMAN, AK
LINDEMANN, RA
NEWMAN, MG
LE, TV
JOURNAL OF DENTAL RESEARCH, 1984, 63 : 186 - 186
[9] Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis
Moskowitz, SM
Foster, JM
Emerson, J
Burns, JL
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (05) : 1915 - 1922
[10] Susceptibility to R-pyocins of Pseudomonas aeruginosa clinical isolates from cystic fibrosis patients
Redero, Mar
Lopez-Causape, Carla
Aznar, Javier
Oliver, Antonio
Blazquez, Jesus
Prieto, Ana I.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (10) : 2770 - 2776

← 1 2 3 4 5 →